[1] Li Y, Ishiguro H, Kawahara T, et al. GATA3 in the urinary bladder: suppression of neoplastic transformation and downregulation by androgens[J]. Am J Cancer Res, 2014, 4(5): 461-473.
[2] 司马晋, 朱明阳, 艾青, 等. NOTCHl/HESl/PTEN信号通路在浸润性膀胱癌中的表达分析[J]. 中华医学杂志, 2012, 92(14): 964-967.
[3] 梁宁, 谢健, 乔丽丽, 等. 半乳糖凝集素3对食管癌Eca109细胞增殖和转移的影响[J]. 国际肿瘤学杂志, 2014, 41(5): 375-379.
[4] 司马晋, 张保, 王保军, 等. 下调Notch1基因对前列腺癌PC3细胞迁移和增殖的影响[J]. 肿瘤研究与临床, 2014, 26(11): 721-724.
[5] 司马晋, 张保, 马鑫, 等. Numb基因对膀胱癌细胞侵袭和迁移能力的影响及机制研究[J]. 中华泌尿外科杂志, 2014, 35(3): 226-229.
[6] Schmittgen TD, Livak KJ. Analyzing realtime PCR data by the comparative C(T) method[J]. Nat Protoc, 2008, 3(6): 1101-1108.
[7] 田野. 应重视肌层浸润性膀胱癌的化疗策略[J]. 中华医学杂志, 2012, 92(2): 363-365.
[8] 朱蕾, 隋华, 邓皖利. 信号通路调控上皮间质转化参与肿瘤侵袭转移的分子机制[J]. 国际肿瘤学杂志, 2014, 41(3): 172-177.
[9] 司马晋, 张保, 杨素霞, 等. 过表达Notch1基因对前列腺癌细胞增殖和周期的影响[J]. 中华实验外科杂志, 2014, 31(6): 1235-1237.
[10] Bechara EG, Sebestyén E, Bernardis I, et al. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation[J]. Mol Cell, 2013, 52(5): 720-733.
[11] Greer RL, Staley BK, Liou A, et al. Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinartoductal metaplasia[J]. Gastroenterology, 2013, 145(5): 1088-1097.
[12] Rennstam K, MeMichael N, Bcerglund P, et al. Numb protein expression correlates with a basallike phenotype and cancer stelll cell markers in primary breast Cancer[J]. Breast Cancer Res Treat, 2010, 122(2): 315-324.
[13] Wu J, Shen SL, Chen B, et al. Numb promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma[J]. PLoS One, 2014, 9(4): e95849.
[14] 刘艳艳, 王潞, 施学兵. CXCR4和CXCL12及PTEN在乳腺癌中的表达及临床意义[J]. 国际肿瘤学杂志, 2013, 40(1): 75-80.
[15] Li Y, Chen M, Yuan J, et al. CXCR4 expression in bladder transitional cell carcinoma and its relationship with clinicopathological features[J]. Urol Int, 2014, 92(2): 157-163.
[16] Retz M, Sidhu S, Blaveri E, et al. CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells[J]. Int J Cancer, 2005, 114(2): 182-189. |